Sweetch Company

Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabetic population, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change. Sweetch developed a proprietary machine-learning platform that predicts an individual’s 3-year risk for developing Metabolic Syndrome related diseases – type 2 diabetes, hypertension, hyperlipidemia, and obesity.
Technology: Machine Learning
Industry: Healthcare
Headquarters: Jerusalem, Yerushalayim, Israel
Founded Date: 2013
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 16
Total Funding: $32M
Estimated Revenue: Less than $1M
Last Funding Date: 19.07.2021
Last Funding Type: Series A

Visit Website
Register and Claim Ownership